Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Long Only ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated

Christophe Eggmann

Christophe Eggmann

Showing manager performance globally. You can view performance in individual jurisdictions.

About Christophe Eggmann

Christophe Eggmann is Portfolio Manager of the JB Health Innovation Fund. He joined GAM Group in November 2010. Prior to that, he held various positions as a fund manager and equity analyst at Bank Hofmann, Rothschild Bank and Credit Suisse. Christophe Eggmann holds a Master in Business Administration and Economics from the University of Neuchâtel and is a CFA Charterholder. He is based in Zurich.

Invests in own strategies

Runs institutional money

Are you Christophe Eggmann?

Citywire Rating: Not Rated


  • MNot rated in May 2013
  • JNot rated in Jun 2013
  • JNot rated in Jul 2013
  • ANot rated in Aug 2013
  • SRated Plus in Sep 2013
  • ORated Plus in Oct 2013
  • NRated Plus in Nov 2013
  • DNot rated in Dec 2013


  • JNot rated in Jan 2014
  • FNot rated in Feb 2014
  • MNot rated in Mar 2014
  • ANot rated in Apr 2014
  • MNot rated in May 2014
  • JNot rated in Jun 2014
  • JNot rated in Jul 2014
  • ANot rated in Aug 2014
  • SNot rated in Sep 2014
  • ONot rated in Oct 2014
  • NNot rated in Nov 2014
  • DNot rated in Dec 2014


  • JNot rated in Jan 2015
  • FNot rated in Feb 2015
  • MRated AA in Mar 2015
  • ARated AA in Apr 2015
  • MRated AA in May 2015
  • JRated AA in Jun 2015
  • JRated AAA in Jul 2015
  • ARated AAA in Aug 2015
  • SRated AAA in Sep 2015
  • ORated AA in Oct 2015
  • NRated AAA in Nov 2015
  • DRated AAA in Dec 2015


  • JRated AA in Jan 2016
  • FRated A in Feb 2016
  • MRated AA in Mar 2016
  • ARated AA in Apr 2016
  • MRated AA in May 2016
  • JRated AA in Jun 2016
  • JRated AA in Jul 2016
  • ARated A in Aug 2016
  • SRated A in Sep 2016
  • ORated A in Oct 2016
  • NRated A in Nov 2016
  • DRated A in Dec 2016


  • JRated Plus in Jan 2017
  • FNot rated in Feb 2017
  • MRated Plus in Mar 2017
  • ARated A in Apr 2017
  • MRated A in May 2017
  • JNot rated in Jun 2017
  • JRated Plus in Jul 2017
  • ARated Plus in Aug 2017
  • SRated Plus in Sep 2017
  • ORated Plus in Oct 2017
  • NNot rated in Nov 2017
  • DNot rated in Dec 2017


  • JNot rated in Jan 2018
  • FNot rated in Feb 2018
  • MNot rated in Mar 2018


Equity - Pharmaceuticals & Health Care
over : 28/02/2015 - 28/02/2018

Total Return

Month by Month Performance

Quarterly Performance

to 01/01/2018 Annual Q1 Q2 Q3 Q4
2017 25.3% 13.6% 6.2% 3.7% 0.1%
2016 -17.9% -15.8% 3.5% 0.5% -6.2%
2015 9.1% 12.3% 4.9% -14.9% 8.8%
2014 32.2% 7.9% 7.7% 6.0% 7.3%
2013 2.3% 12.9% 13.3%

Related News

Up in smoke: the SRI case for marijuana

Medicinal cannabis has surged in popularity but should investors experiment? Leading managers explain the SRI case for the legal high.

Healthcare industry fighting fit after Trump win

From pricing pressures to Obamacare overhauls, leading managers reveal what the election impact for healthcare could be.

Pfizer power play: healthcare stars react to $14bn deal

Citywire Selector canvassed sector specialists on what the pharma giant’s latest purchase means for M&A and long-term investments.

Pfizer & Allergan's abandoned mega-merger: what happens next

As pharmaceutical giant halts its merger with Allergan, Citywire Selector asked if the sector had cracked its M&A addiction.

Health scares: GAM star Eggmann on the mad year for the sector

Citywire AA-rated Christophe Eggmann on how innovation, major corrections and revolutionary treatments are proving healthy bets for his strategy.

US Treasury can’t restrain M&A boom, says healthcare star

VIDEO: AAA-rated Christophe Eggmann thinks Pfizer will buy Allergan despite authority's plans to stop tax-inversion deals.

Healthcare M&A is scaring investors, says GAM star

Citywire AA-rated healthcare specialist Christophe Eggmann thinks a number of business models in the industry are only focused on price hikes.

Healthcare manager to depart Swiss & Global AM

Sector specialist set to end six year stint with Zurich-based asset management group later this month.

Swiss & Global unveils raft of equity fund mergers

Asset management firm set to combine several similar strategies in order to streamline global equity fund range.

Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.